TGA Approval

PLUVICTO lutetium (177Lu) vipivotide tetraxetan 1000 MBq/mL solution for injection vial (410282)

ARTG ID

410282

ARTG Name

PLUVICTO lutetium (177Lu) vipivotide tetraxetan 1000 MBq/mL solution for injection vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

July 17, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/34b99d1f96094e5983505289faa3e85d.pdf

https://medical-cdn.nocode.com/drug_tga/792515f77473601b93e266cd51b85f65.pdf

Ingredient Name

lutetium (177Lu) vipivotide tetraxetan

Empowering clinical research with data-driven insights and AI-powered tools.